COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
3.910
+0.120 (3.17%)
At close: May 12, 2025, 4:00 PM
3.980
+0.070 (1.79%)
After-hours: May 12, 2025, 7:58 PM EDT
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $363.04 million as of May 12, 2025. Its market cap has decreased by -34.42% in one year.
Market Cap
363.04M
Enterprise Value
134.96M
1-Year Change
-34.42%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $363.04M, a decrease of -36.15%. That is a compound annual growth rate of -9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 351.90M | 36.06% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |